Home Insmed

Insmed

In operation
Seasoned Equity Offering
Developer of Novel Targeted Inhalation Therapies
Basic
Enterprise Profile

Basic Information

Insmed is a listed biopharmaceutical company dedicated to improving the lives of patients with serious lung diseases by developing and commercializing novel targeted inhaled therapies for patients with highly unmet needs in orphan lung diseases.
Insmed Inc.
NewJersey,United States of America
51~100 people
January 01, 1988
BusinessDevelopment@insmed.com

Enterprise Profile

Industrial Sector
New Drug Development
Technology
Targeted Technology
Concept
Therapeutic Products Pulmonary Heart Disease Pulmonary Tuberculosis
Application Scenarios
Biologics Innovative Drugs